MedTrace Logo

Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer

NCT00003763 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-09-30

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures using the drug radiolabeled folic acid and imaging may be effective in detecting ovarian cancer.

PURPOSE: Diagnostic trial to study the effectiveness of radiolabeled folic acid plus imaging in detecting ovarian cancer.

Conditions

Interventions

PROCEDURE

radionuclide imaging

RADIATION

indium In 111 folic acid

Sponsors & Collaborators

  • Endocyte

    lead INDUSTRY

Principal Investigators

  • David M. Gershenson, MD · M.D. Anderson Cancer Center

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-12-08
Primary Completion
2000-05-03
Completion
2000-05-03
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003763 on ClinicalTrials.gov